top of page
Breast Cancer Risk Reduction Options: Preventive Medication, Risk-Reducing Mastectomy, and Who Should Consider Them

Breast Cancer Risk Reduction Options: Preventive Medication, Risk-Reducing Mastectomy, and Who Should Consider Them

ป้าหมอนุช
1 hour ago
4 min read

People at higher-than-average breast cancer risk have several levels of risk-reducing options: lifestyle changes, enhanced screening, risk-reducing medication (chemoprevention), which can roughly halve risk, and risk-reducing mastectomy, which lowers risk by more than 90% in BRCA carriers. The right choice depends on risk level, age and personal preference. At Namarak Hospital, breast surgeons assess risk and provide genetic counseling in-house, and can perform nipple-sparing mastectomy with immediate reconstruction for those who choose preventive surgery.

Who is at high risk?

  • Carriers of gene mutations such as BRCA1, BRCA2, PALB2 or TP53 — see BRCA genes and family history

  • Several relatives with breast or ovarian cancer, or cancer at a young age

  • Previous high-risk lesions such as ADH, ALH or LCIS — see High-risk breast lesions

  • Chest radiation before age 30

  • High risk on models such as Tyrer–Cuzick (IBIS): lifetime risk of 20% or more, or high 5-year risk

1. Lifestyle (for everyone)

  • Weight control, especially after menopause

  • Regular exercise

  • Limit or avoid alcohol

  • Breastfeed when possible

  • Use menopausal hormone therapy only as needed — see Risk factors and prevention

2. Enhanced screening

High-risk people start screening earlier and more often, such as yearly MRI with mammography for BRCA carriers; under the Thai guideline, mammography with ultrasound may be alternated with MRI. Screening finds cancer early but does not lower the chance of developing it — see Breast MRI

3. Risk-reducing medication (chemoprevention)

  • Tamoxifen 20 mg for 5 years — lowers the risk of hormone receptor-positive cancer by about 30–50%, before or after menopause; key side effects are blood clots and, rarely, uterine cancer — see Tamoxifen side effects

  • Low-dose tamoxifen 5 mg for 3 years — the TAM-01 trial roughly halved new cancers in people with ADH, LCIS or DCIS, with fewer side effects

  • Raloxifene — for postmenopausal women, with fewer clots and uterine effects than tamoxifen

  • Aromatase inhibitors (anastrozole, exemestane) — for postmenopausal women, roughly halving risk (IBIS-II, MAP.3); bone health needs attention — see Aromatase inhibitors and bone health

  • The USPSTF recommends offering risk-reducing medication to women at increased risk and low risk of side effects, but not to women at average risk

4. Risk-reducing surgery

Bilateral risk-reducing mastectomy

  • Lowers breast cancer risk by more than 90% in BRCA1/BRCA2 carriers

  • Can be nipple-sparing with immediate reconstruction for a natural appearance — see Nipple-sparing mastectomy

  • Not recommended for average-risk people or for anxiety alone

  • Downsides include reduced skin and nipple sensation and reconstruction complications; allow enough counseling and time to decide

Risk-reducing salpingo-oophorectomy

  • Recommended for BRCA1 carriers at 35–40 and BRCA2 carriers at 40–45, after childbearing is complete

  • Greatly lowers ovarian cancer risk and overall mortality

  • Planned together with a specialist gynecologist

How to choose

The decision depends on risk level, age, family plans, acceptable side effects and personal feelings; there is no single right answer. Discuss options with a breast surgeon and seek genetic counseling — see Multigene panel genetic testing

Frequently asked questions (FAQ)

How effective is preventive medication?

Tamoxifen, raloxifene and aromatase inhibitors lower the risk of hormone receptor-positive breast cancer by about 30–50%, and suit high-risk people with low risk of side effects.

Do all BRCA carriers need a mastectomy?

No. It is one option that lowers risk by more than 90%; another is enhanced screening with MRI and mammography. The decision is individual.

Can cancer still develop after preventive mastectomy?

A small risk remains because not every cell of breast tissue can be removed, but risk falls by more than 90%.

Can the nipple be preserved in preventive mastectomy?

In most people, yes. Nipple-sparing mastectomy with immediate reconstruction gives a natural appearance.

Who should have a breast cancer risk assessment?

People with a family history of breast or ovarian cancer, previous high-risk lesions, or chest radiation at a young age should consult a breast surgeon for assessment and planning.

About Namarak Hospital

Namarak Hospital is a specialized breast and breast cancer hospital in Bangkok, providing complete care in one place — from diagnosis with 3D mammography, ultrasound, automated breast ultrasound (ABUS) and biopsy to comprehensive breast cancer treatment, including breast-conserving and reconstructive surgery, intraoperative radiotherapy (IORT), chemotherapy, targeted therapy and endocrine therapy, planned by a multidisciplinary team according to the latest international guidelines. See Breast cancer treatment: a complete guide, contact us on LINE, tel. +66 2 059 0245, or our Second Opinion service.

Related articles

References

  • US Preventive Services Task Force. Medication Use to Reduce Risk of Breast Cancer: Recommendation Statement. JAMA 2019;322:857–67

  • Visvanathan K, et al. Use of Endocrine Therapy for Breast Cancer Risk Reduction: ASCO Clinical Practice Guideline Update. J Clin Oncol 2019;37:3152–65

  • Cuzick J, et al. Use of anastrozole for breast cancer prevention (IBIS-II): long-term results. Lancet 2020;395:117–22

  • DeCensi A, et al. Low-Dose Tamoxifen (TAM-01). J Clin Oncol 2019;37:1629–37

  • Tung NM, et al. Management of Hereditary Breast Cancer: ASCO, ASTRO, and SSO Guideline. J Clin Oncol 2020;38:2080–106

  • NCCN Clinical Practice Guidelines in Oncology: Breast Cancer Risk Reduction; Genetic/Familial High-Risk Assessment, 2026

Medically reviewed by: Namarak Hospital medical team · Last checked: 17 November 2026 · This information is for general education and is not individual medical advice. Please consult your doctor for diagnosis and treatment suited to you.

Comments


Link to the Namarak Hospital medical team profiles
bottom of page